Top Markets
Coin of the day
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

THRX
Ранг среди акций #19950
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on... Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.
Цена акции
$4.06
Последняя синхронизация: 2024-02-23
Рыночная капитализация
$145.61M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Theseus Pharmaceuticals, Inc. (THRX)

Категория

История дроблений акций Theseus Pharmaceuticals, Inc. (THRX)
Акции Theseus Pharmaceuticals, Inc. (символ: THRX) прошли через 0 дроблений.
Последнее дробление произошло Aug 25, 2026.
Одна акция THRX, купленная до Aug 25, 2026, сейчас соответствует 0 акциям THRX.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH